Definitive Contract HHSD200201691964C
- Not listed
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for a Stool Microbiome Study. The contract has a ceiling value of $263,231 and was awarded on September 9, 2016, with a completion date of September 14, 2017. The contract is a firm fixed-price arrangement. The University of Pennsylvania is a renowned private research university...
- The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), awarded a $683,280 firm-fixed-price contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, for a project titled "Targeted Reduction of Antimicrobials". This contract, which does not have a set-aside designation, was awarded on September 14, 2016 with a completion date of June 19, 2018. The University of...
- This is a $745,301.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract supports FY21 Broad Agency Announcement (BAA) Topic 8 research, which is civilian in nature and has no set-aside designation. The period of performance runs through May 14, 2022. The Trustees of the University of Pennsylvania, a private university and...
- This is a $451,533 firm fixed-price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to The Trustees of the University of Pennsylvania (Penn), a private university and non-profit organization. The contract does not have a set-aside designation. The contract supports biomedical research and aligns with the CDC's priorities. Penn will conduct quality control and analysis of whole genome sequencing data from...
- The University of Pennsylvania will deliver research services to the Centers for Disease Control and Prevention under a three-year, $672,276 firm fixed price contract. Awarded through the Department of Health and Human Services' Broad Agency Announcement 2020 Topic 3.1 solicitation, the University will support CDC programs in Philadelphia, conducting work aligned with the agency's disease prevention and public health missions. As the prime contractor, the University of Pennsylvania's Clinical...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $481,788.00 definitive contract to The Trustees of the University of Pennsylvania (Penn), a private university and non-profit organization, to conduct research related to antibiotic resistant drugs and long-term acute care patients. This is a cost-no-fee contract with a completion date of September 18, 2019. Penn has a history of receiving federal research and development funding from agencies such...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $598,990.00 firm-fixed-price definitive contract to The Trustees of the University of Pennsylvania (Penn) to conduct research on colonization with multidrug-resistant gram-negative bacteria in Botswana. The contract was awarded on September 30, 2018 and has a completion date of September 29, 2020. Penn is a private university and non-profit organization that conducts biomedical research, provides...
- This is a $49,794 firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to The Pennsylvania State University (Penn State) to develop a computational fluid dynamics (CFD) model for analyzing the aerodynamic behavior of aerosols and droplets. The contract does not have a set-aside designation, indicating Penn State was selected based on technical merit and capability. Penn State is a large public research university with extensive experience in...
- This is a $750,000.00 definitive contract awarded to The Pennsylvania State University (Penn State) by the Centers for Disease Control and Prevention (CDC) on September 30, 2022. The contract, which has a period of performance through September 14, 2023, is for research and development under a Broad Agency Announcement (BAA) with no set-aside designation. Penn State is a public land-grant research university with extensive experience as a federal contractor and grantee, supporting national...
- This is a $776,352.00 firm fixed-price definitive contract awarded by the Defense Contract Audit Agency (DCAA) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract has no set-aside designation and was awarded on September 21, 2017, with a completion date of December 20, 2020. The contract falls under the National Interest Action Code for Coronavirus COVID-19 and involves providing global perspectives on...
This firm-fixed-price federal contract, valued at $393,011.00, was awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of the University of Pennsylvania (Penn) to conduct a respiratory microbiome study. The contract does not have a set-aside designation. Penn, a renowned private research university and academic medical center, has a long history of performing advanced biomedical research and providing healthcare services to the federal government through contracts and grants. This contract supports the CDC's research objectives by providing critical data to facilitate the development of medical countermeasures against emerging, infectious, and bioterror agents. Penn may leverage its expertise and partnerships to execute this work.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Supplemental Agreement for work within scope | $0 | 11/27/18 | |
| 1 | Other Administrative Action | $0 | 8/4/17 | |
| Not listed | Not listed | $393.0k | 9/23/16 |